HIGHLIGHTS
- who: Francesco Menzella from the (UNIVERSITY) have published the article: Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes, in the Journal: (JOURNAL)
- what: This study showed a close relationship between baseline BEC and the clinical efficacy of mepolizumab, with efficacy increasing progressively with increasing BEC. In this trial, transient eosinophilia was reported in approximately 14% of patients on active therapy, with normalisation occurring by the end of the treatment period and no patients experiencing clinically relevant adverse events . In all the investigations, respiratory function was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.